← Leaderboards
Eric Ervin
Electronic Biosciences, Inc.
$11,673,833
Attributed
$11,673,833
Total exposure
22
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,673,833 · 22
By mechanism
R44$5,526,127 · 3
R43$4,105,158 · 13
R41$965,740 · 3
N43$637,612 · 2
R21$439,196 · 1
Top collaborators
No co-investigators on record.
Most similar at Electronic Biosciences, Inc.
Same institution · by research overlap
- Anna Schibel$4,844,195
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsNanoporeBaseSamplingMethodologyTechnologyElectronicsBiological SciencesDiagnosticDetectionLipid BilayersPrototypeEvaluationCostPrognosticHemolysinNucleotidesModificationMeasurementMutantReaderPreparationElectrodesExonuclease
Grant awards (27)
Rapid Fingerstick Diagnostics for Opioid and Stimulant Use Disorders$386,452
R43 · FY2025 · DA · contact PI
High-Resolution Pseudouridine and m6A Sequencing Through Advanced Nanopore Adduct Analysis$350,000
R41 · FY2025 · GM · contact PI
TOPIC 455: IDEAL AT-HOME PROSTATE SPECIFIC ANTIGEN (PSA) TESTING$389,535
N43 · FY2024 · CA · contact PI
Nanoscale Tools for Inosine Sequencing$1,000,000
R44 · FY2023 · HG · contact PI
Nanopores for Processing Proteins$407,291
R43 · FY2023 · HG · contact PI
Sequencing the Mono-Methylated Derivatives of Cytidine$400,000
R43 · FY2023 · HG · contact PI
Point-of-Care Assay for Type 1 Diabetes Diagnosis and Prognostication$284,517
R43 · FY2023 · DK · contact PI
Nanoscale Tools for Inosine Sequencing$1,000,000
R44 · FY2022 · HG · contact PI
Exonuclease Based Microsatellite Sequencing$400,000
R43 · FY2022 · CA · contact PI
Comprehensive Botulinum Characterization via the Bilayer Nanowell Integrated Assay$400,000
R43 · FY2022 · NS · contact PI
Dual Reader Protein Sequencing$394,141
R43 · FY2022 · HG · contact PI
Long-lived Platform Development for Exonuclease-Based Sequencing$399,999
R41 · FY2021 · HG · contact PI
Exonuclease Epigenetic Sequencing$896,993
R44 · FY2020 · HG · contact PI
N6-Methyl-2'-O-Methyladenosine Sequencing$400,000
R43 · FY2020 · CA · contact PI
Exonuclease Epigenetic Sequencing$889,978
R44 · FY2019 · HG · contact PI
The Bilayer Nanopore Integrated Assay for Complete Toxin Characterization, Phase II$712,787
R44 · FY2018 · NS · contact PI
Exonuclease Epigenetic Sequencing$276,492
R44 · FY2018 · HG · contact PI
Nanopore Based Exonuclease Enabled DNA Sequencing$276,487
R43 · FY2018 · HG · contact PI
The Bilayer Nanopore Integrated Assay for Complete Toxin Characterization, Phase II$749,877
R44 · FY2017 · NS · contact PI
Nanoscale Tools for RNA Modification SequencingPOP: 9/18/17 through 6/17/18$248,077
N43 · FY2017 · CA · contact PI
Nanopore Enabled Exonuclease Sequencing$224,997
R43 · FY2016 · HG · contact PI
Optimizing Nanopore Protein Interactions$204,204
R21 · FY2016 · EB · contact PI
Optimizing Nanopore Protein Interactions$234,992
R21 · FY2015 · EB · contact PI
Bilayer Nanopore Integrated Assay$179,651
R43 · FY2015 · NS · contact PI
Identification and Quantification of Sequence Specific RNA Modifications via the Alpha-Hemolysin Latch Zone$215,741
R41 · FY2014 · DA · contact PI
Encapsulated Lipid Bilayer Based Assay for Assessing Botulinum Neurotoxin Potency$184,864
R43 · FY2012 · NS · contact PI
Nanopore Based Methods for Enantiomer Differentiation$166,758
R43 · FY2010 · GM · contact PI